Alitair Pharmaceuticals Overview
- Year Founded
-
2010
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$6.16M
Alitair Pharmaceuticals General Information
Description
Operator of a pharmaceutical company intended for bronchiectasis as well as leveraging proprietary ion-exchange resin formulations. The company's patented formulation acts as a passive drug formulation system to reduce the risk of prescription drug overdose irrespective of the number of tablets or capsules ingested, enabling medical professionals to treat and patients to get relief from respiration-related diseases.
Contact Information
Website
www.alitairpharmaceuticals.comCorporate Office
- 99 Derby Street
- Suite 200
- Hingham, MA 02034
- United States
Corporate Office
- 99 Derby Street
- Suite 200
- Hingham, MA 02034
- United States
Alitair Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series B) | 11-Nov-2020 | $6.16M | 00.000 | 000.00 | Completed | Generating Revenue |
| 3. Later Stage VC | 09-Oct-2018 | 00000 | 00.000 | Completed | Generating Revenue | |
| 2. Seed Round | 10-Feb-2017 | $100K | $1.01M | Completed | Generating Revenue | |
| 1. Angel (individual) | 29-Sep-2015 | $911K | $911K | Completed | Generating Revenue |
Alitair Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | 00,000,000 | 00.000000 | 00 | 00 | 00 | 00 | 00 | 00.000 |
| Series A | 00,000,000 | 00.000000 | 00 | 00 | 00 | 00 | 00 | 00.000 |
Alitair Pharmaceuticals Comparisons
Industry
Financing
Details
000000
000000
Alitair Pharmaceuticals Competitors (3)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Cerecin | Venture Capital-Backed | Singapore, Singapore | 00 | 00000 | 0000000000 0 | 00000 |
| Alzheon | Venture Capital-Backed | Framingham, MA | 00 | 00000 | 00000000000 | 00000 |
| Neurocrine Biosciences | Formerly VC-backed | San Diego, CA | 0000 | 00000 | 00000000 | 00000 |
Alitair Pharmaceuticals Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Alitair Pharmaceuticals Patents
Alitair Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20150265621-A1 | Treating bronchiectasis with doxofylline and erdosteine | Inactive | 22-Mar-2014 | 0000000000 | 0 |
| US-9211292-B2 | Preventing or reducing drug abuse and overdose events | Inactive | 05-Aug-2011 | 0000000000 | 0 |
| US-20130096191-A1 | Benzonatate compositions and methods of use | Active | 20-Oct-2010 | 0000000000 | |
| US-8808743-B2 | Benzonatate compositions and methods of use | Active | 20-Oct-2010 | 0000000000 | 0 |
| US-20150150809-A1 | Immediate release compositions and methods for delivering drug formulations using weak acid ion exchange resins in abnormally high ph environments | Inactive | 03-Sep-2010 | A61K9/209 | 0 |
Alitair Pharmaceuticals Executive Team (6)
| Name | Title | Board Seat |
|---|---|---|
| James Hoyes | Chief Executive Officer, Board Member & Chairman | |
| Helmut Albrecht MD | Chief Scientific Officer & Key Consultant |
Alitair Pharmaceuticals Board Members (3)
| Name | Representing | Role | Since |
|---|---|---|---|
| James Hoyes | Alitair Pharmaceuticals | Chief Executive Officer, Board Member & Chairman | 000 0000 |
| Robert Casale | Self | Board Member | 000 0000 |
Alitair Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Alitair Pharmaceuticals FAQs
-
When was Alitair Pharmaceuticals founded?
Alitair Pharmaceuticals was founded in 2010.
-
Who is the founder of Alitair Pharmaceuticals?
William Howard Ph.D is the founder of Alitair Pharmaceuticals.
-
Who is the CEO of Alitair Pharmaceuticals?
James Hoyes is the CEO of Alitair Pharmaceuticals.
-
Where is Alitair Pharmaceuticals headquartered?
Alitair Pharmaceuticals is headquartered in Hingham, MA.
-
What is the size of Alitair Pharmaceuticals?
Alitair Pharmaceuticals has 3 total employees.
-
What industry is Alitair Pharmaceuticals in?
Alitair Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Alitair Pharmaceuticals a private or public company?
Alitair Pharmaceuticals is a Private company.
-
What is the current valuation of Alitair Pharmaceuticals?
The current valuation of Alitair Pharmaceuticals is 000.00.
-
What is Alitair Pharmaceuticals’s current revenue?
The current revenue for Alitair Pharmaceuticals is 000000.
-
How much funding has Alitair Pharmaceuticals raised over time?
Alitair Pharmaceuticals has raised $7.29M.
-
Who are Alitair Pharmaceuticals’s competitors?
Cerecin, Alzheon, and Neurocrine Biosciences are competitors of Alitair Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
